盐酸苯海拉明(溶出数据库)

"品种编号","品种","规格(支)","","单价","申请数量","金额","备注" 171201,"吗啡","200mg","171201-200318","156.25 "171202,"盐酸地芬诺酯","50mg","171202-200303","37.50 "171203,"磷酸可待因","50mg","171203-200303","62.50 "171204,"枸椽酸芬太尼","200mg","171204-200303","106.25 " 171205,"福尔可定","100mg","171205-200303","106.25 "171206,"盐酸海洛因","20mg","171206-9710","250.00 ",,,"毒品分析用" 171207,"O6-单乙酰吗啡盐酸盐","20mg","171207-200310","175.00 ",,,"毒品分析用"171208,"O3-单乙酰吗啡氨基磺酸盐","20mg","171208-0106","175.00 ",,,"毒品分析用"171209,"乙酰可待因","20mg","171209-200305","175.00 ",,,"毒品分析用" 171210,"盐酸可卡因","100mg","171210-9201","37.50 ",,,"毒品分析用" 171211,"硫酸安非它明","50mg","171211-9301","62.50 ",,,"毒品分析用" 171212,"盐酸甲基安非它明","20mg","171212-9802","125.00 ",,,"毒品分析用"171213,"盐酸哌替啶","100mg","171213-200302","62.50 ",,,"毒品分析用" 171214,"盐酸罂粟碱","100mg","171214-9602","37.50 "171215,"咖啡因","100mg","171215-200305","87.50 "171216,"蒂巴因","100mg","171216-0102","62.50 "171217,"硝西泮","100mg","171217-200302","62.50 "171218,"阿普唑仑","100mg","171218-9702","62.50 "171219,"艾司唑仑","100mg","171219-0102","62.50 "171220,"巴比妥","100mg","171220-9201","37.50 "171221,"异戊巴比妥","100mg","171221-200302","62.50 "171222,"苯巴比妥","100mg","171222-200303","87.50 "171223,"司可巴比妥钠","100mg","171223-9201","37.50 "171224,"那可丁","100mg","171224-9902","37.50 "171225,"地西泮","100mg","171225-9601","87.50 "171227,"氯硝西泮","100mg","171227-200302","175.00 ""麻醉药对照品申请表""申请单位: 填表日期: 年月日""品种编号","品种","规格(支)","","单价","申请数量","金额","备注" 171228,"2-氨基-2'-氯-5-硝基二苯酮","100mg","171228-9701","37.50 " 171229,"奥沙西泮","100mg","171229-200302","175.00 "171230,"三唑仑","100mg","171230-9701","75.00 "171231,"盐酸爱康宁","20mg","171231-0104","175.00 "171232,"盐酸甲基爱康宁","20mg","171232-9902","175.00 "171233,"苯甲酰爱康宁","20mg","171233-0204","225.00 "171234,"大麻酚溶液 (1mg/ml)","0.3ml","171234-0207","100.00 " 171235,"大麻二酚溶液 (1mg/ml)","0.3ml","171235-9907","100.00 " 171237,"盐酸伪麻黄碱","100mg","171237-200103","87.50 "171238,"硫酸吗啡","100mg","1238-0103","106.25 "171239,"盐酸纳洛酮","50mg","171239-9701","250.00 "171240,"(-)-4,5-α-环氧基-3,14-二羟基吗啡喃-6-酮","20mg","1240-9701","106.25 "171241,"盐酸麻黄碱","100mg","171241-200102","87.50 "171242,"盐酸曲马多","100mg","171242-200302","87.50 "171243,"盐酸美沙酮","100mg","171243-200001","62.50 "171244,"盐酸丁丙诺啡","100mg","171244-200001","250.00 " 171245,"MDMA","20mg","171245-0101","212.50 ",,,"毒品分析用" 171246,"盐酸洛非西定","20mg","171246-200301","250.00 "171247,"盐酸甲基麻黄碱","100mg","171247-200301","87.50 " 171248,"氯氮卓","100mg","171247-200301","87.50 ""单位负责人(印章): 麻醉药品主管人(印章): 药品监督管理部门公章:" "注:1,申请数量栏请用大写,写成"计伍支"字样.不需要的品种写"零支",不要留空.填写完毕后请在所填数字上加盖公章."" 2,药品监督管理部门指单位所在地的药品监督管理部门."" 3,申请盐酸海洛因需经省药品监督管理局盖章."" 4,以上对照品不邮寄,请派人带此表来取.""2004年标准品目录""2004年药品检验用标准品,对照品,标准试剂征订单""序号","品种编号","名称","类别","用途","","规格","单价","申请量","金额","备注"1,100001,"醋酸甲羟孕酮","对照品","含量测定","100001-9503","50mg","100.00 "2,100002,"安乃近","对照品","检查","0002-9504","500mg","12.50 "3,100003,"(+)2-氨基丁醇","对照品","检查","0003-200303","100mg","37.50 "4,100004,"苯丙酸诺龙","对照品","含量测定","0004-8102","50mg","100.00 "5,100005,"苯丁酸氮芥","对照品","含量测定","0005-9402","50mg","100.00 "6,100006,"苯甲酸雌二醇","对照品","含量测定","0006-9703","100mg","125.00 "7,100008,"丙酸睾酮","对照品","含量测定","0008-9404","50mg","62.50 " 8,100010,"醋酸氟氢松","对照品","含量测定","0010-0206","50mg","187.50 "9,100011,"醋酸氯地孕酮","对照品","鉴别","0011-8501","50mg","12.50 " 10,100012,"醋酸泼尼松","对照品","含量测定","10012-0105","100mg","62.50 "11,100013,"醋酸氢化可的松","对照品","含量测定","10013-0106","50mg","100.00 "12,100015,"地高辛","对照品","含量测定","10015-0208","30mg","125.00 " 13,100016,"地塞米松磷酸钠","对照品","含量测定","10016-0011","100mg","125.00 "14,100017,"对氨基苯甲酸","对照品","检查","10017-0107","50mg","25.00 "15,100018,"对乙酰氨基酚","对照品","检查","10018-0107","1000mg","62.50 "16,100021,"泛影酸","对照品","鉴别","0021-8102","200mg","12.50 "17,100022,"甘罗溴铵","对照品","含量测定","0022-9302","100mg","100.00 "18,100023,"谷氨酸","对照品","鉴别","0023-8601","50mg","12.50 "19,100024,"磺胺","对照品","检查","0024-8702","50mg","12.50 "20,100025,"磺胺甲恶唑","对照品","含量测定","0025-9503","50mg","100.00 "21,100026,"磺胺嘧啶","对照品","含量测定","0026-8601","50mg","100.00 " 22,100027,"黄体酮","对照品","含量测定","100027-200301","50mg","100.00 "23,100028,"炔诺孕酮","对照品","含量测定","0028-9907","100mg","62.50 " 24,100029,"甲萘醌","对照品","含量测定","100029-200009","50mg","62.50 "25,100030,"甲巯咪唑","对照品","检查","0030-9703","100mg","25.00 " 26,100031,"甲氧苄啶","对照品","含量测定","0031-200304","50mg","100.00 "27,100032,"己酸羟孕酮","对照品","含量测定","0032-8501","50mg","100.00 "28,100033,"己烯雌酚","对照品","含量测定","0033-9805","50mg","100.00 " 29,100034,"枸橼酸氯米芬","对照品","含量测定","0034-9702","50mg","100.00 "30,100035,"甲磺酸双氢麦角毒碱","对照品","含量测定","0035-9701","50mg","100.00 "31,100037,"克霉唑","对照品","鉴别","10037-200306","200mg","62.50 " 32,100038,"邻甲苯磺酰胺","对照品","检查","0038-9802","50mg","12.50 " 33,100039,"6-巯基嘌呤","对照品","检查","0039-9601","50mg","37.50 " 34,100040,"硫酸阿托品(毒)","对照品","含量测定","0040-9109","50mg","100.00 ""2004年药品检验用标准品,对照品,标准试剂征订单""序号","品种编号","名称","类别","用途","","规格","单价","申请量","金额","备注"35,100041,"利血平","对照品","含量测定","10041-0210","100mg","187.50 " 36,100042,"2-氯-4-硝基苯胺","对照品","检查","10042-0002","50mg","25.00 "37,100043,"氯普噻吨","对照品","检查","0043-9701","50mg","25.00 "38,100045,"咪唑","对照品","检查","0045-9903","50mg","12.50 "39,100046,"吡喹酮","对照品","含量测定","100046-200304","50mg","125.00 "40,100047,"马来酸氯苯那敏","对照品","鉴别","100047-200305","50mg","125.00 "41,100049,"氢溴酸东莨菪碱 (毒)","对照品","含量测定","0049-200308"," 50mg","100.00 "42,100050,"氢溴酸加兰他敏","对照品","检查","0050-7801","50mg","12.50 "43,100052,"炔雌醇","对照品","含量测定","100052-200308","50mg","250.00 "44,100053,"炔诺酮","对照品","含量测定","0053-200204","50mg","250.00 " 45,100054,"4-N-去甲基安乃近","对照品","检查","0054-9503","500mg","12.50 "46,100055,"曲安萘德","对照品","含量测定","100055-200302","50mg","125.00 "47,100056,"去乙酰毛花甙(毒)","对照品","含量测定","0056-9302","50mg","100.00 "48,100058,"乳糖","对照品","含量测定","0058-9501","200mg","100.00 " 49,100060,"酞丁安","对照品","含量测定","100060-200302","50mg","125.00 "50,100061,"VD3","对照品","含量测定","10061-0206","50mg","62.50 "51,100062,"VE","对照品","含量测定","10062-0007","160mg","62.50 "52,100063,"戊酸雌二醇","对照品","含量测定","0063-9503","100mg","125.00 "53,100065,"盐酸胺碘酮","对照品","含量测定","100065-200304","200mg","125.00 "54,100066,"盐酸苯海拉明","对照品","含量测定","0066-9705","200mg","100.00 "55,100067,"盐酸苯海索","对照品","含量测定","0067-7801","1000mg","100.00 "56,100068,"盐酸多沙普仑","对照品","含量测定","0068-9701","50mg","100.00 "57,100069,"盐酸多塞平","对照品","检查","0069-9702","50mg","62.50 " 58,100070,"盐酸多巴胺","对照品","含量测定","0070-9404","200mg","50.00 "59,100071,"盐酸可乐定","对照品","含量测定","0071-9905","100mg","100.00 "60,100072,"盐酸克仑特罗","对照品","含量测定","0072-8501","50mg","100.00 "61,100073,"盐酸芬氟拉明","对照品","含量测定","10073-0002","100mg","62.50 "62,100075,"荧光母素","对照品","检查","0075-7902","100mg","12.50 " 63,100076,"左炔诺孕酮","对照品","含量测定","0076-8801","50mg","100.00 "64,100077,"胆红素","对照品","含量测定","10077-0301","50mg","125.00 " 65,100078,"胆酸","对照品","含量测定","10078-0013","500mg","25.00 " 66,100080,"芦丁","对照品","含量测定","100080-200306","200mg","125.00 "67,100082,"葡萄糖酸钙","对照品","检查","0082-9701","50mg","25.00 " 68,100083,"匹莫林","对照品","检查","0083-9501","50mg","25.00 ""2004年药品检验用标准品,对照品,标准试剂征订单""序号","品种编号","名称","类别","用途","批号","规格","单价","申请量","金额","备注"69,100084,"酒石酸美托洛尔","对照品","含量测定","10084-0101","50mg","37.50 "70,100085,"氟哌利多","对照品","含量测定","0085-9701","50mg","100.00 " 71,100086,"硝基呋喃丙烯酸","对照品","检查","0086-8302","100mg","12.50 "72,100088,"克罗米通","对照品","含量测定","0088-9801","100mg","100.00 "73,100089,"双羟萘酸噻嘧啶","对照品","含量测定","100089-200301","50mng","100.00 "74,100090,"双羟萘酸","对照品","含量测定","100090-200301","50mg","100.00 "75,100091,"酚酞","对照品","含量测定","0091-9601","100mg","100.00 " 76,100093,"香草醛","对照品","熔点测定用","0093-8403","每套10个品种,1g/支.","375.00 ",,,"成套发放,不零售.",100094,"乙酰苯胺","对照品","熔点测定用","0094-0204",100095,"非那西丁","对照品","熔点测定用","0095-8904",100096,"磺胺","对照品","熔点测定用","0096-9404",100097,"茴香酸","对照品","熔点测定用","0097-9402",100098,"磺胺二甲嘧啶 ","对照品","熔点测定用","0098-8303",100099,"双氰胺","对照品","熔点测定用","0099-8403",100100,"糖精","对照品","熔点测定用","0100-8403",100101,"咖啡因","对照品","熔点测定用","0101-8403",100102,"酚酞","对照品","熔点测定用","0102-9404"77,100103,"水杨酸片","对照品","溶出度校正片","10103-200208","7片/包","37.50 "78,100105,"氨基己酸","对照品","鉴别","0105-9902","50mg","12.50 "79,100106,"水杨酸","对照品","含量测定","0106-9702","100mg","37.50 " 80,100107,"溴甲阿托品","对照品","鉴别","0107-9501","50mg","12.50 " 81,100109,"α-甲基吡啶","对照品","含量测定","10109-0201","50mg","37.50 "82,100110,"甲磺酸酚妥拉明","对照品","含量均匀度","0110-9501","50mg","100.00 "83,100111,"盐酸萘甲唑林","对照品","含量测定","10111-0103","100mg","62.50 "84,100113,"阿司匹林","对照品","含量测定","10113-200302","300mg","37.50 "85,100114,"氨苯砜","对照品","检查","0114-9101","50mg","37.50 "86,100115,"烟酰胺","对照品","含量测定","10115-0001","50mg","62.50 " 87,100116,"盐酸吡哆辛","对照品","含量测定","0116-9801","50mg","100.00 "88,100117,"阿替洛尔","对照品","含量测定","0117-9903","50mg","37.50 "89,100118,"倍他米松","对照品","含量测定","0118-9502","50mg","62.50 " 90,100119,"丙酸倍氯米松","对照品","含量测定","0119-9802","50mg","125.00 "91,100121,"茶碱","对照品","检查","100121-199903","50mg","100.00 " 92,100122,"醋酸地塞米松","对照品","含量测定","100122-200304","50mg","250.00 "93,100123,"醋酸可的松","对照品","含量测定","100123-200303","50mg","125.00 ""2004年药品检验用标准品,对照品,标准试剂征订单""序号","品种编号","名称","类别","用途","","规格","单价","申请量","金额","备注"94,100124,"醋酸泼尼松龙","对照品","含量测定","100124-200303","50mg","125.00 "95,100125,"醋酸曲安奈德","对照品","含量测定","10125-0103","50mg","125.00 "96,100126,"达那唑","对照品","含量测定","0126-9101","50mg","100.00 " 97,100127,"胆石酸","对照品","检查","0127-9701","50mg","25.00 "98,100128,"地蒽酚","对照品","含量测定","10128-0201","50mg","62.50 " 99,100129,"地塞米松","对照品","含量测定","100129-200303","50mg","187.50 "100,100130,"丁溴东莨菪碱","对照品","含量测定","0130-9501","50mg","62.50 "101,100131,"对甲苯磺酰胺","对照品","检查","0131-9501","50mg","25.00 " 102,100132,"对羟基苯乙酰胺","对照品","检查","0132-9702","50mg","25.00 "103,100133,"奋乃静","对照品","含量测定","0133-9601","50mg","100.00 " 104,100134,"酚磺乙胺","对照品","含量测定","0134-9302","50mg","100.00 "105,100135,"格列本脲","对照品","含量测定","10135-0103","50mg","100.00 "106,100136,"10%A晶型甲苯咪唑","对照品","检查","0136-9301","50mg","62.50 "107,100138,"甲氨蝶呤","对照品","含量测定","0138-9702","50mg","100.00 "108,100139,"甲苯咪唑 ","对照品","鉴别","0139-9702","50mg","25.00 " 109,100140,"6-甲氧基-2-萘乙酮","对照品","检查","100140-200303","50mg","62.50 "110,100141,"N-甲基哌嗪","对照品","检查","0141-9301","50mg","12.50 " 111,100142,"卡马西平","对照品","含量测定","0142-9503","50mg","37.50 " 112,100143,"硫喷妥","对照品","含量测定","0143-9101","50mg","100.00 " 113,100144,"磷酸咯萘啶","对照品","含量测定","10144-0001","50mg","125.00 "114,100145,"苯丙氨酯","对照品","含量测定","0145-9501","50mg","125.00 "115,100146,"哈西奈德","对照品","含量测定","0146-9502","50mg","62.50 " 116,100147,"氯化胆碱","对照品","检查","100147-200302","50mg","100.00 "117,100148,"氯化琥珀胆碱","对照品","检查","0148-9301","50mg","12.50 " 118,100149,"4-[2-(5-氯-2-甲氧基苯甲酰胺)-乙基]-苯磺酰胺","对照品","检查","10149-0202","50mg","125.00 "119,100150,"4-[2-(5-氯-2-甲氧基苯甲酰胺)-乙基]-苯磺酰胺基-甲酸乙酯","对照品","检查","10150-0202","50mg","125.00 "120,100151,"吡哌酸","对照品","检查","0151-9202","50mg","25.00 "121,100152,"氢化可的松","对照品","含量测定","0152-0206","50mg","100.00 "122,100153,"泼尼松龙","对照品","含量测定","0153-9302","50mg","50.00 " 123,100154,"肾上腺素","对照品","含量测定","100154-200301","50mg","125.00 "124,100155,"维生素D2","对照品",,"10155-0004","50mg","62.50 "125,100156,"维生素K1","对照品","含量测定","10156-0003","50mg","62.50 "126,100157,"硝酸毛果芸香碱(毒)","对照品","含量测定","10157-0201","50mg","62.50 ""2004年药品检验用标准品,对照品,标准试剂征订单""序号","品种编号","名称","类别","用途","","规格","单价","申请量","金额","备注"127,100158,"西咪替丁","对照品","鉴别","0158-9303","50mg","25.00 " 128,100160,"盐酸丙咪嗪","对照品","检查","0160-9602","50mg","12.50 " 129,100161,"盐酸地尔硫 ","对照品",,"10161-0102","100mg","37.50 " 130,100163,"盐酸雷尼替丁","对照品","含量测定","10163-0004","50mg","37.50 "131,100165,"盐酸乙胺丁醇","对照品","检查","10165-0103","50mg","25.00 "132,100167,"盐酸左旋咪唑","对照品","检查","0167-9202","50mg","18.75 " 133,100168,"盐酸奈福泮","对照品","含量测定","10168-0101","50mg","37.50 "134,100169,"重酒石酸去甲肾上腺素","对照品","含量测定","0169-9505","100mg","100.00 "135,100170,"左旋多巴","对照品","含量测定","0170-9302","50mg","100.00 "136,100171,"醋酸甲地孕酮","对照品","含量测定","10171-0103","50mg","37.50 "137,100172,"甲睾酮","对照品","含量测定","0172-9702","50mg","50.00 " 138,100173,"布美他尼","对照品","检查","0173-9301","50mg","25.00 " 139,100174,"氨甲环酸","对照品","检查","0174-9501","50mg","25.00 " 140,100175,"胡椒乙腈","对照品","检查","10175-0201","50mg","37.50 " 141,100176,"丙谷胺","对照品","检查","10176-0003","50mg","25.00 " 142,100177,"吡罗昔康","对照品","检查","0177-9802","50mg","25.00 "143,100179,"布洛芬","对照品","含量测定","0179-9702","50mg","37.50 " 144,100180,"倍他米松磷酸钠","对照品","含量测定","0180-9401","50mg","125.00 "145,100181,"比沙可啶","对照品","鉴别","0181-9501","50mg","12.50 " 146,100182,"雌二醇","对照品","含量测定","10182-0103","50mg","125.00 " 147,100183,"醋酸氯己定","对照品","含量测定","0183-9902","50mg","100.00 "148,100184,"双氢青蒿素","对照品","检查","100184-200302","50mg","125.00 "149,100185,"莪术醇","对照品","含量测定","100185-200305","200mg","250.00 "150,100186,"2,6-二甲基酚","对照品","检查","10186-0201","50mg","37.50 "151,100188,"环戊噻嗪","对照品","含量测定","0188-9701","50mg","100.00 "152,100189,"甲基多巴","对照品","含量测定","0189-9501","50mg","62.50 " 153,100190,"甲芬那酸","对照品","检查","0190-9501","50mg","18.75 " 154,100191,"甲硝唑","对照品","含量测定","100191-200305","200mg","125.00 "155,100192,"联苯双酯","对照品","含量测定","0192-9501","50mg","100.00 "156,100193,"螺内酯","对照品","检查","0193-9601","50mg","37.50 "157,100194,"碘化钾","对照品","含量测定","10194-0001","50mg","62.50 " 158,100195,"氯噻酮","对照品","含量测定","0195-9701","50mg","37.50 " 159,100196,"邻位甲酚","对照品","含量测定","0196-200302","1000mg","100.00 "160,100197,"硫唑嘌呤","对照品","检查","0197-9601","50mg","25.00 " "2004年药品检验用标准品,对照品,标准试剂征订单""序号","品种编号","名称","类别","用途","","规格","单价","申请量","金额","备注"161,100198,"萘普生","对照品","含量测定","10198-0002","50mg","62.50 " 162,100199,"泼尼松","对照品","含量测定","0199-9401","50mg","62.50 " 163,100200,"青蒿琥酯","对照品","检查","0200-0202","50mg","62.50 " 164,100201,"氢溴酸右美沙芬","对照品","检查","0201-9901","50mg","25.00 "165,100203,"舒必利","对照品","含量测定","0203-9702","100mg","50.00 " 166,100204,"沙丁胺醇","对照品","含量测定","0204-9701","50mg","37.50 " 167,100206,"双氰胺","对照品","检查","0206-200302","50mg","37.50 " 168,100208,"水杨酸镁","对照品","含量测定","10208-0102","50mg","37.50 "169,100209,"司坦唑醇","对照品","含量测定","0209-9401","50mg","50.00 " 170,100211,"辛可尼丁","对照品","检查","0211-9601","50mg","12.50 " 171,100212,"溴甲贝那替嗪","对照品","检查","0212-9701","50mg","25.00 " 172,100213,"硝酸咪康唑","对照品","含量测定","0213-9903","100mg","62.50 "173,100214,"硝酸益康唑","对照品","含量测定","0214-9802","100mg","50.00 "174,100216,"盐酸安他唑啉","对照品","含量测定","0216-9701","50mg","100.00 "175,100217,"盐酸苯丙醇胺","对照品","含量测定","100217-200303","200mg","125.00 "176,100218,"盐酸美西律","对照品","含量测定","0218-9601","50mg","100.00 "177,100219,"盐酸酚苄明","对照品","含量测定","0219-9902","50mg","100.00 "178,100220,"盐酸氯丙那林","对照品","含量测定","0220-9401","50mg","100.00 "179,100221,"氢醌","对照品","检查","100221-200301","50mg","100.00 " 180,100222,"盐酸罗通定","对照品","鉴别","0222-9401","50mg","62.50 " 181,100223,"盐酸维拉帕米","对照品","含量测定","0223-9601","50mg","100.00 "182,100224,"异维A酸","对照品","含量测定","10224-0202","50mg","125.00 "183,100225,"贝诺酯","对照品","含量测定","0225-9601","50mg","100.00 " 184,100226,"半乳糖","对照品","含量测定","0226-0103","50mg","100.00 " 185,100228,"醋酸甲萘氢醌","对照品","含量测定","0228-9802","50mg","100.00 "186,100229,"富马酸氯马斯汀","对照品","检查鉴别","0229-9601","50mg","62.50 "187,100230,"富马酸酮替芬","对照品","含量测定","0230-9501","50mg","100.00 "188,100231,"果糖","对照品","含量测定","100231-200304","50mg","100.00 "189,100232,"环吡酮胺","对照品","鉴别","100232-200305","50mg","125.00 "190,100233,"环己胺","对照品",,"100233-200301","50mg","125.00 "191,100235,"己内酰胺","对照品","检查","0235-9701","50mg","25.00 " 192,100236,"硝酸甘油","对照品","含量测定","0236-0201","2mg/ml","37.50 "193,100237,"磷酸苯丙哌啉","对照品","含量测定","0237-9701","50mg","37.50 "194,100238,"米诺地尔","对照品","含量测定","0238-9701","50mg","37.50 " "2004年药品检验用标准品,对照品,标准试剂征订单""序号","品种编号","名称","类别","用途","","规格","单价","申请量","金额","备注"195,100241,"羟甲香豆素","对照品","含量测定","0241-9902","100mg","100.00 "196,100244,"双嘧达莫","对照品","检查","0244-9701","50mg","25.00 "。

药物分析练习题B 答案一、名词解释1.精密称定：指称取重量应准确至所取重量的千分之一。

2.标准品系指用于生物检定，抗生素或生化药品中含量或效价测定的标准物质，按效价单位（或ug）计，以国际标准品进行标定。

3.一般鉴别试验：一般鉴别试验是依据某一类药物的化学结构或理化性质的特征，通过化学反应来鉴别药物的真伪。

4.定量限：指样品中被测物能被定量测定的最低量，其测定结果应具有一定的准确度和精密度。

5.特殊杂质：指在特定药物的生产和贮藏过程中引入的杂质。

二、填空题1.药典中规定的杂质检查项目，是指该药品在生产和贮藏中可能含有并需要控制的杂质。

2.古蔡氏检砷法的原理为金属锌与酸作用产生H2 ,与药物中微量砷盐反应生成具挥发性的AsH3 ,遇溴化汞试纸，产生黄色至棕色的砷斑，与一定量标准砷溶液产生的砷斑比较，判断药物中砷盐的含量。

3.巴比妥类药物的母核为1,3-二酰亚胺结构，为环状的丙二酰脲结构。

巴比妥类药物常为白色结晶或结晶性粉末，环状结构与碱共热时，可发生水解开环。

巴比妥类药物本身不溶于水，易溶于乙醇等有机溶剂，其钠盐易溶于水而不溶于有机溶剂。

4.对乙酰氨基酚含有酚羟基，与三氯化铁发生呈色反应，可与利多卡因和醋氨苯砜区别。

5.铈量法测定氯丙嗪含量时，当氯丙嗪失去1 个电子显红色，失去2 个电子红色消褪。

6.绿奎宁反应为喹啉类衍生物的特征反应，在酸性水溶液中，滴加微过量的溴水或氯水，再加入过量的氨水，应显绿色。

7.甾体激素类药物分子结构中存在�6�2 1,3 -4-酮基和苯环共轭系统，在紫外光区有特征吸收。

8.链霉素的结构是由一分子链霉胍和一分子链霉双糖胺结合而成的碱性苷。

9.四环素类抗生素在酸性溶液中会发生差向异构化，当pH 小于2 或pH 大于6 时差向异构化速度减小。

10.中国药典的主要内容由凡例、正文、附录和索引四部分组成。

三、选择题1.杂质限量是指药物中所含杂质的最大允许量2.药物的中金属检查中（第一法），溶液的酸碱度通常是弱酸性3.药物氯化物检查中所用的酸是稀硝酸4.药物杂质限量检查的结果是1.0ppm，表示药物所含杂质的重量是药物本身重量的百万分之一5.药物中氯化物检查的意义可以考核生产工艺是否正常和反映药物的纯度水平6.砷盐检查中，为了除去供试品中可能含有的微量硫化物的影响，在导气管中需填装蘸有下列溶液的药棉醋酸铅7.微孔滤膜法是用来检查重金属8.古蔡法检查砷盐中Zn和HCl的作用是D.生成新生台H2↑9.干燥失重主要是检查药物中A.水分及其他挥发性成分10.检查维生素C中重金属：取样2.0g，规定含重金属不得过百万分之十，应吸取标准铅溶液（每1ml=0.01mg的Pb）多少ml C. 2.0ml11.两步滴定法测定阿司匹林的含量时，每1ml氢氧化钠溶液（0.1mol/L）相当于阿司匹林（分子量=180.16）的量是E.18.02mg12.阿司匹林片剂的含量测定采用两步滴定法是因为A.片剂中有酸性稳定剂和分解产物13.阿司匹林的酸碱滴定中，要求采用中性乙醇做溶剂，所谓“中性”是指A.对所用指示剂显中性14.盐酸丁卡因与硝酸作用形成B.N-亚硝基化合物15.药物分子中具有下列哪一基团才能在酸性溶液中直接用亚硝酸钠液滴定C.芳伯氨基16.不能直接与三氯化铁试液反应的药物是D阿司匹林17.苯巴比妥在吡啶溶液中与铜离子作用，生成的络合物颜色为 B.紫色18.哪个药物与吡啶—硫酸酮作用，生成绿色配位化合物E.硫喷妥钠19.银量法测定苯巴比妥的含量，现版中国药典采用什么方法指示终点 E电位滴定法20.能使碘试液褪色的药物是B司可巴比妥四、简答题1.简述维生素C 的主要化学性质。

盐酸苯海拉明工艺规程1.引言1.1 概述盐酸苯海拉明是一种重要的有机合成中间体，在医药和化工领域具有广泛的应用。

本文旨在探讨盐酸苯海拉明的工艺规程，以期通过对生产流程、原料准备、反应条件控制等方面的介绍，为盐酸苯海拉明的制备提供指导和参考。

盐酸苯海拉明的工艺流程是一系列复杂的化学反应，需要精确的控制条件和高质量的原料。

通过本文的研究，可以更好地了解盐酸苯海拉明的制备过程，并提供一些改善和优化的建议。

在本文中，我们将首先介绍盐酸苯海拉明工艺规程的概述，包括其基本原理和应用领域。

然后，我们将详细介绍文章的结构和内容安排，以便读者能够更好地理解和阅读本文。

本文的目的在于提供一个全面而详尽的盐酸苯海拉明工艺规程，以指导和帮助从业人员正确地进行盐酸苯海拉明的制备工作。

通过本文的研究成果，我们希望能够为相关领域的研究和实践者提供有价值的参考和指导，并为今后的研究和发展提供新的思路和方向。

在接下来的章节中，我们将详细介绍盐酸苯海拉明的工艺流程，包括原料准备、反应条件控制等方面的内容。

我们将详细描述每个环节的操作步骤和注意事项，以确保生产过程的安全和高效。

同时，我们还将探讨盐酸苯海拉明的工艺优势以及相关的质量控制措施，以确保产品的优质和稳定性。

最后，我们将对盐酸苯海拉明的工艺规程进行总结，并展望未来的发展方向和挑战。

我们将提出一些可能的改进和创新方案，以期为盐酸苯海拉明的制备和应用带来更大的发展潜力。

总之，本文的概述部分为读者提供了对盐酸苯海拉明工艺规程的整体了解，并介绍了本文的结构和内容安排。

接下来的章节中，我们将对工艺流程、原料准备、反应条件控制等方面进行详细的介绍和讨论。

通过本文的研究，我们希望为相关领域的从业人员提供有用的信息和指导，推动盐酸苯海拉明的制备技术的进一步发展和应用。

1.2文章结构1.2 文章结构本文将按照以下结构进行叙述和讨论盐酸苯海拉明的工艺规程：1. 引言：在引言部分，将对盐酸苯海拉明进行概述，介绍其重要性和应用领域。

中检院国家药品标准物质目录第 1 页，共 52 页第 2 页，共 52 页第 3 页，共 52 页第 4 页，共 52 页第 5 页，共 52 页第 6 页，共 52 页第 7 页，共 52 页第 8 页，共 52 页第 9 页，共 52 页第 10 页，共 52 页第 11 页，共 52 页第 12 页，共 52 页第 13 页，共 52 页第 14 页，共 52 页第 15 页，共 52 页第 16 页，共 52 页第 17 页，共 52 页第 18 页，共 52 页第 19 页，共 52 页第 20 页，共 52 页第 21 页，共 52 页第 22 页，共 52 页第 23 页，共 52 页第 24 页，共 52 页第 25 页，共 52 页第 26 页，共 52 页第 27 页，共 52 页第 28 页，共 52 页第 29 页，共 52 页第 30 页，共 52 页第 31 页，共 52 页第 32 页，共 52 页第 33 页，共 52 页第 34 页，共 52 页第 35 页，共 52 页第 36 页，共 52 页第 37 页，共 52 页第 38 页，共 52 页第 39 页，共 52 页第 40 页，共 52 页第 41 页，共 52 页第 42 页，共 52 页第 43 页，共 52 页第 44 页，共 52 页第 45 页，共 52 页第 46 页，共 52 页第 47 页，共 52 页第 48 页，共 52 页第 49 页，共 52 页第 50 页，共 52 页。

盐酸苯海拉明缓释片的制备刘欣洋;董锐;于洋懿;葛冰;胡湘婷;韩翠艳(指导)【期刊名称】《中国高新科技》【年(卷),期】2024()2【摘要】目的 :制备24h缓释的盐酸苯海拉明缓释片。

方法 :建立盐酸苯海拉明紫外分光光度法的含量测定方法;以片剂成型情况确定制备工艺;以释放度为评价指标,筛选盐酸苯海拉明缓释片的骨架材料,确定处方;根据优选的处方工艺制备盐酸苯海拉明缓释片,考察其质量。

结果 :紫外分光光度法:在纯化水中的标准曲线:y=0.0015x+0.015,r=0.9998,线性范围:130.5~451.7μg/mL;在模拟胃液中的标准曲线:y=0.0016x-0.0074,r=0.9993,线性范围:130.5~401.5μg/mL;在模拟小肠液中的标准曲线:y=0.0016x-0.0041,r=0.9991,线性范围:130.4~401.5μg/mL;在模拟结肠液中的标准曲线:y=0.0016x-0.0179,r=0.9991,线性范围:150.5~401.5μg/mL。

精密度和回收率符合规定。

优选的处方工艺为:盐酸苯海拉明75mg、乙基纤维素360mg、滑石粉15mg,粉末直接压片,压力70N。

通过优选的处方及制备工艺制备的盐酸苯海拉明缓释片,片剂表面光滑整洁,片重差异及在不同释放介质中的释放度均在80%以上。

结论 :以乙基纤维素为骨架材料制备的不溶性盐酸苯海拉明骨架片,可缓慢释放24h,制备工艺简单,造价成本低。

【总页数】4页(P113-116)【作者】刘欣洋;董锐;于洋懿;葛冰;胡湘婷;韩翠艳(指导)【作者单位】齐齐哈尔医学院药学院【正文语种】中文【中图分类】R969【相关文献】1.盐酸苯海拉明口崩片制备工艺探讨2.复方盐酸苯海拉明凝胶的制备与质量控制3.盐酸苯海拉明凝胶的制备及质量控制4.盐酸苯海拉明口崩片的制备工艺及质量控制研究5.盐酸苯海拉明糖浆的制备及质量控制因版权原因，仅展示原文概要，查看原文内容请购买。

盐酸苯海拉明原研晶型盐酸苯海拉明（Hydrochloride of Phenylpiracetam）是一种晶型，它具有许多重要的应用和研究价值。

本文将从以下几个方面对盐酸苯海拉明原研晶型进行介绍。

盐酸苯海拉明是一种白色结晶体，具有良好的稳定性和溶解性。

它可以在常温下稳定保存，并且可以在水中迅速溶解，便于制备和使用。

这使得盐酸苯海拉明在医药领域中应用广泛。

盐酸苯海拉明具有多种药理作用。

研究表明，它可以增强大脑的认知功能和记忆能力，改善学习和记忆能力。

此外，它还具有抗疲劳和抗抑郁的作用，可以提高身体的适应能力和抵抗力。

这些作用使得盐酸苯海拉明在治疗认知障碍、神经衰弱和抑郁症等疾病方面具有潜在的价值。

盐酸苯海拉明的研究晶型对其性质和应用有着重要的影响。

研究发现，盐酸苯海拉明晶型的结构与其溶解性和稳定性密切相关。

通过研究晶型，可以优化盐酸苯海拉明的制备工艺和质量控制，提高其药效和稳定性，从而更好地满足临床需求。

盐酸苯海拉明的晶型也对其溶解度和生物利用度的研究具有重要意义。

研究发现，不同晶型的盐酸苯海拉明在体内的溶解度和吸收速度有所不同，这对于药物的吸收和代谢有着重要的影响。

通过研究晶型，可以优化盐酸苯海拉明的药物给药途径和剂型设计，提高其生物利用度和治疗效果。

盐酸苯海拉明原研晶型具有重要的应用和研究价值。

通过对其晶型的研究，可以优化其制备工艺和质量控制，提高其药效和稳定性；同时，还可以优化药物给药途径和剂型设计，提高其生物利用度和治疗效果。

我们相信，在未来的研究中，盐酸苯海拉明晶型的研究将会取得更多的突破和进展，为临床治疗和科学研究提供更好的支持和指导。

一致性评价重磅参考资料：（USP1092）溶出度试验的开发和验证2015-12-25刘建华医药信息新药开发译者：刘建华国药集团工业有限公司前言目的：溶出度试验的开发和验证（1092）目的是为溶出度的测定提供了全面的开发和验证的方法以及相应的分析技术。

本指导原则贯穿溶出度测定的全部过程，并对方法验证提供了指导和验证标准。

同时它还涉及对普通制剂和缓释制剂产生的数据和接受标准进行说明。

范围：本指导原则讨论了溶出度试验的开发和验证，重点是固体口服剂型。

所提出的概念也可能适用于其他剂型和给药途径。

对于一些不同于USP章节中的设备和程序均已给出合适的解释。

本指导原则的基本框架如下：1.前期评估（对产品开发以及溶出度方法开发的前期研究评估）1.1滤膜相容性研究（Performing Filter Compatibility）1.2原料药在不同溶媒中溶解度和稳定性的测定1.3选择溶出介质和体积1.4选择溶出设备（桨法和篮法以及其他方法）2.方法开发2.1脱气2.2沉降2.3搅拌2.4研究设计2.4.1取样时间点2.4.2观察2.4.3取样2.4.4清洗2.5数据处理2.6溶出度试验的评估3.分析整理3.1样品的处理3.2过滤3.3离心3.4分析过程3.5光谱分析3.6HPLC分析4.程序化4.1溶出介质的准备4.2样品的选择和取样时间的设计4.3取样和过滤4.4清洗4.5使用软件和计算机处理结果4.6找出需要验证的存在偏差的过程5.验证5.1专属性/安慰剂的干扰5.2线性和范围5.3准确度/回收率5.4精密度试验5.4.1重复性试验5.4.2中间精密度试验5.4.3重现性试验5.5耐用性试验5.6对照品和供试品的稳定性试验5.7程序化验证6.接受标准6.1普通速释制剂6.2缓释制剂6.3控释制剂6.4多重溶出度试验6.5溶出度结果的解释6.5.1普通速释制剂6.5.2缓释制剂6.5.3控释制剂7.参考文献1. 前期评估（对产品发展以及溶出度方法开发的前期研究评估）在方法开发之前，对用以评价剂型的溶出行为的滤膜、溶出介质、介质体积和溶出设备进行筛选是非常重要的。